相关实验视频
Updated: Mar 3, 2026

05:58
Tissue Triage and Freezing for Models of Skeletal Muscle Disease
Published on: July 15, 2014
41.5K
神经病学文献中有什么内容?
Michael Isfort1, David Lacomis2
1Department of Neurology, The Neuroscience Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH; and.
Journal of clinical neuromuscular disease
|March 2, 2026
概括
本综述涵盖可治疗的肌肉病变,包括与诸如塞特拉林和他类药物相关的肌肉病,以及诸如肌肉发育不良和庞培病等遗传疾病.
科学领域:
- 神经学 神经学
- 肌肉疾病 肌肉疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 肌肉病症包括一系列肌肉疾病,具有不同的病因.
- 了解具体的原因和表现对于有效的管理至关重要.
- 最近的研究揭示了药物诱导,遗传和自身免疫性肌肉病变.
研究的目的:
- 为了解决和治疗各种肌肉病的最新进展提供全面的概述.
- 突出可治疗的肌肉病变,包括与药物和特定遗传条件相关的肌肉病变.
- 审查肌肉发育不良,庞培病和肌性疾病的关键发现.
主要方法:
- 关于肌肉病的最新报告和研究的文献综述.
- 讨论特定的神经病变的类别,包括脂质储存,单克隆性骨髓病变相关的,与他类药物相关的,有毒的,免疫介导的和遗传形式.
- 专注于治疗反应条件和新出现的治疗数据.
主要成果:
- 鉴定了与塞特拉林和罗纳拉相关的可治疗的脂质储存肌病.
- 讨论了与单克隆性甘马病相关的神经病变,包括一种对治疗有反应性的糖原储存形式.
- 审查了与他类药物相关的肌肉症状,有毒肌肉病变,免疫媒介性化肌肉病变和其他自身免疫肌肉病变.
- 覆盖的肌肉发育不良症 (肌肉发育不良症,四肢腰带,骨头骨),庞培病 (酶替代疗法),先天性肌肉发育不良症和肌肉发育不良症.
结论:
- 各种肌肉病,包括药物诱导和遗传形式,是可以治疗的.
- 对佩病和肌肉发育不良等疾病的理解和治疗方面正在取得进展.
- 本综述综合了有关多种肌肉病的当前知识,强调了诊断和治疗方面的进展.
相关概念视频
Disorders of the Skeletal Muscle
2.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K
Myasthenia Gravis: Diagnostic Tests
2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
Satellite Stem Cells and Muscular Dystrophy
2.5K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K
Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
Muscle Contraction
97.4K
97.4K
Muscle Contraction
9.1K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
9.1K

